Authors: Feighner, JP Ehrensing, RH Kastin, AJ Patel, A Sverdlov, L Hlavka, J Abajian, HB Noble, JF Nicolau, G

Citation: Jp. Feighner et al., Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression, INT CLIN PS, 16(6), 2001, pp. 345-352

Authors: Feighner, JP Sverdlov, L Nicolau, G Noble, JF

Citation: Jp. Feighner et al., Cluster analysis of clinical data to identify subtypes within a study population following treatment with a new pentapeptide antidepressant, IN J NEUROP, 3(3), 2000, pp. 237-242

Authors: Feighner, JP Ehrensing, RH Kastin, AJ Leonard, BE Sverdlov, L Nicolau, G Patel, A Hlavka, J Abajian, H Noble, JF

Citation: Jp. Feighner et al., A double-blind, placebo-controlled, efficacy, safety, and pharmacokinetic study of INN 00835, a novel antidepressant peptide, in the treatment of major depression, J AFFECT D, 61(1-2), 2000, pp. 119-126

Authors: Kelly, JP Nicolau, G Redmond, A Leonard, BE Noble, J Sverdlov, L Molinar, R Kastin, AJ Ehrensing, RH Feighner, JP

Citation: Jp. Kelly et al., The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients, J AFFECT D, 55(2-3), 1999, pp. 231-235